What are the best treatments for Kabuki syndrome?

There is currently no single curative treatment for Kabuki syndrome, so medical management focuses on a multidisciplinary, symptom-based approach tailored to each individual's unique clinical profile. Treatment for Kabuki syndrome involves coordinating care across various specialties to address specific concerns such as developmental delays, cardiac anomalies, and endocrine imbalances.

How is Kabuki syndrome managed clinically?

Because Kabuki syndrome is a multisystem genetic condition, there is no "one-size-fits-all" treatment protocol. Instead, clinicians focus on proactive surveillance and early intervention. The primary goal is to optimize the quality of life for individuals with Kabuki syndrome by addressing the specific physiological and developmental challenges that arise from infancy through adulthood. Because the clinical presentation of Kabuki syndrome is highly variable, treatment effectiveness differs significantly from person to person; for example, one child may require surgical intervention for a cardiac defect, while another may primarily need intensive speech and occupational therapy.

What are the primary therapeutic approaches for Kabuki syndrome?

Management of Kabuki syndrome relies heavily on non-pharmacological therapies and specialized medical support. Medications are used only to treat secondary conditions, such as seizures or endocrine deficiencies. The following interventions are commonly recommended:

• Physical and Occupational Therapy: Essential for addressing hypotonia (low muscle tone) and motor delays common in children with Kabuki syndrome.


• Speech and Language Therapy: Used to support communication development, as many individuals experience delays in speech acquisition.


• Endocrine Support: Regular monitoring for growth hormone deficiency, which is observed in a subset of patients and may be treated with recombinant human growth hormone (somatropin) if clinically indicated.


• Surgical Intervention: Necessary for structural issues such as congenital heart defects, cleft palate, or ocular abnormalities.


• Educational Accommodations: Individualized Education Programs (IEPs) are vital for managing the mild-to-moderate intellectual disability associated with the condition.

Which specialists should be on the care team?

Due to the complexity of Kabuki syndrome, a multidisciplinary team is essential. Care should be coordinated by a clinical geneticist or pediatrician, supported by a range of specialists depending on the patient's symptoms. This team typically includes cardiologists for heart monitoring, neurologists for seizure management, ophthalmologists for vision screenings, and gastroenterologists for feeding issues. At DiseaseMaps.org, our community of 50 members living with Kabuki syndrome emphasizes the importance of consistent communication between these specialists to ensure no symptom is overlooked.

Are there emerging treatments for Kabuki syndrome?

While no gene-editing or curative therapies exist, research is ongoing. Clinical literature and animal model studies have investigated epigenetic modulators, such as histone deacetylase (HDAC) inhibitors, which aim to address the underlying molecular mechanism of Kabuki syndrome. However, these remain experimental and are not currently part of standard clinical practice. Families are encouraged to consult their physicians regarding potential participation in clinical trials listed on reputable registries.

Next steps

• Consult with a board-certified clinical geneticist to establish a comprehensive surveillance plan tailored to your family member’s needs.


• Ensure your child has a dedicated care coordinator to manage appointments across specialties.


• Join the DiseaseMaps.org community to connect with other families and share experiences regarding local therapists and specialists.


• Review the latest clinical trial updates through the NIH ClinicalTrials.gov portal.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; all treatment decisions must be made in consultation with your personal healthcare team.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Kabuki syndrome overview.


• Orphanet: Rare disease database entry for Kabuki syndrome.


• OMIM (Online Mendelian Inheritance in Man): Clinical synopsis of KMT2D and KDM6A mutations.


• All Things Kabuki: Patient advocacy and support resources.